[Treatment of acute sinusitis using new quinoline chemotherapeutic agents]

The author compared in an open clinical trial during treatment of acute sinusitis the therapeutic results of two new quinoline chemotherapeutic preparations--Tarivid and Ciproxine. The drugs were administered to a total of 40 patients. In both groups (à 20 patients) clinical recovery occurred in 95% of the patients. The preparations were well tolerated and no manifestations of allergy or marked intolerance were observed. Regular haematological and biochemical tests did not reveal a pathological rise of parameters. No difference was revealed in the therapeutic effectiveness of the two drugs.